Obstructive sleep apnea phenotypes and cardiovascular risk: Is there a role for heart rate variability in risk stratification?
作者信息
Carter Jason R, Mokhlesi Babak, Thomas Robert J
机构信息
Department of Health and Human Development, Montana State University, Bozeman, MT, USA.
Department of Medicine, Section of Pulmonary and Critical Care, Sleep Disorders Center, The University of Chicago, Chicago, IL, USA.
出版信息
Sleep. 2021 May 14;44(5). doi: 10.1093/sleep/zsab037.
Abstract
摘要
相似文献
1
Obstructive sleep apnea phenotypes and cardiovascular risk: Is there a role for heart rate variability in risk stratification?阻塞性睡眠呼吸暂停表型与心血管风险：心率变异性在风险分层中起作用吗？
Sleep. 2021 May 14;44(5). doi: 10.1093/sleep/zsab037.
2
Physiology May Be the Key: Cardiovascular Risk Stratification in Obstructive Sleep Apnea.生理学可能是关键：阻塞性睡眠呼吸暂停的心血管风险分层
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1458-1460. doi: 10.1164/rccm.202101-0145ED.
3
Obstructive Sleep Apnea Symptom Subtypes and Cardiovascular Risk: Conflicting Evidence to an Important Question.阻塞性睡眠呼吸暂停症状亚型与心血管风险：一个重要问题的相互矛盾的证据
Am J Respir Crit Care Med. 2022 Mar 15;205(6):729-730. doi: 10.1164/rccm.202111-2467LE.
4
Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association.阻塞性睡眠呼吸暂停与心血管疾病：美国心脏协会科学声明
Circulation. 2021 Jul 20;144(3):e56-e67. doi: 10.1161/CIR.0000000000000988. Epub 2021 Jun 21.
5
Haptoglobin polymorphism is a risk factor for cardiovascular disease in patients with obstructive sleep apnea syndrome.触珠蛋白多态性是阻塞性睡眠呼吸暂停综合征患者心血管疾病的一个危险因素。
Sleep. 2003 Aug 1;26(5):592-5. doi: 10.1093/sleep/26.5.592.
6
[Cardiovascular risk and obstructive sleep apnea].[心血管风险与阻塞性睡眠呼吸暂停]
Pan Afr Med J. 2018 Jan 18;29:47. doi: 10.11604/pamj.2018.29.47.11267. eCollection 2018.
7
Editorial Commentary: Biomarkers of cardiovascular risk in obstructive sleep apnea - innovation or illusion?社论评论：阻塞性睡眠呼吸暂停综合征中心血管风险的生物标志物——是创新还是幻觉？
Trends Cardiovasc Med. 2021 May;31(4):250-251. doi: 10.1016/j.tcm.2020.04.009. Epub 2020 May 11.
8
Comparison of cardiovascular risk in co-existent primary aldosteronism and obstructive sleep apnea with neither or either alone in hypertension.高血压患者中并存原发性醛固酮增多症和阻塞性睡眠呼吸暂停与单独患有其中一种或两者都无的心血管风险比较。
Eur J Intern Med. 2023 Dec;118:146-148. doi: 10.1016/j.ejim.2023.09.011. Epub 2023 Sep 15.
9
Obstructive Sleep Apnea in Cardiovascular Disease: A Review of the Literature and Proposed Multidisciplinary Clinical Management Strategy.心血管疾病中的阻塞性睡眠呼吸暂停：文献综述及多学科临床管理策略建议
J Am Heart Assoc. 2019 Jan 8;8(1):e010440. doi: 10.1161/JAHA.118.010440.
10
Reply to Keenan : Obstructive Sleep Apnea Symptom Subtypes and Cardiovascular Risk: Conflicting Evidence to an Important Question.对基南的回复：阻塞性睡眠呼吸暂停症状亚型与心血管风险：一个重要问题的相互矛盾的证据。
Am J Respir Crit Care Med. 2022 Mar 15;205(6):730-732. doi: 10.1164/rccm.202111-2567LE.
引用本文的文献
1
Reliability of heart rate variability during stable and disrupted polysomnographic sleep.稳定和中断的多导睡眠图睡眠期间心率变异性的可靠性。
Am J Physiol Heart Circ Physiol. 2022 Jul 1;323(1):H16-H23. doi: 10.1152/ajpheart.00143.2022. Epub 2022 May 13.
2
Sympathetic neural responses to sleep disorders and insufficiencies.对睡眠障碍和不足的交感神经反应。
Am J Physiol Heart Circ Physiol. 2022 Mar 1;322(3):H337-H349. doi: 10.1152/ajpheart.00590.2021. Epub 2022 Jan 7.
3
The Different Facets of Heart Rate Variability in Obstructive Sleep Apnea.阻塞性睡眠呼吸暂停中心率变异性的不同方面
Front Psychiatry. 2021 Jul 22;12:642333. doi: 10.3389/fpsyt.2021.642333. eCollection 2021.
本文引用的文献
1
Heart rate variability during wakefulness as a marker of obstructive sleep apnea severity.清醒时心率变异性作为阻塞性睡眠呼吸暂停严重程度的标志物。
Sleep. 2021 May 14;44(5). doi: 10.1093/sleep/zsab018.
2
The Role of Heart Rate Variability in the Future of Remote Digital Biomarkers.心率变异性在远程数字生物标志物未来发展中的作用。
Front Neurosci. 2020 Nov 13;14:582145. doi: 10.3389/fnins.2020.582145. eCollection 2020.
3
Changes in heart rate variability (HRV) in patients with severe and moderate obstructive sleep apnea before and after acute CPAP therapy during nocturnal polysomnography.重度和中度阻塞性睡眠呼吸暂停患者在夜间多导睡眠图期间急性持续气道正压通气（CPAP）治疗前后的心率变异性（HRV）变化。
Sleep Sci. 2020 Apr-Jun;13(2):97-102. doi: 10.5935/1984-0063.20200003.
4
Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial.阻塞性睡眠呼吸暂停及其经持续气道正压通气治疗对急性冠状动脉综合征患者心血管事件发生率的影响（ISAACC 研究）：一项随机对照试验。
Lancet Respir Med. 2020 Apr;8(4):359-367. doi: 10.1016/S2213-2600(19)30271-1. Epub 2019 Dec 12.
5
Very low frequency component of heart rate variability as a marker for therapeutic efficacy in patients with obstructive sleep apnea: Preliminary study.心率变异性的极低频成分作为阻塞性睡眠呼吸暂停患者治疗效果的标志物：初步研究。
J Res Med Sci. 2019 Sep 30;24:84. doi: 10.4103/jrms.JRMS_62_18. eCollection 2019.
6
Novel heart rate variability index for wrist-worn wearable devices subject to motion artifacts that complicate measurement of the continuous pulse interval.新型心率变异性指数，适用于腕戴式可穿戴设备，可减轻运动伪影对连续脉搏间隔测量的影响。
Physiol Meas. 2019 Nov 4;40(10):105010. doi: 10.1088/1361-6579/ab4c28.
7
Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis.基于文献的分析估计全球阻塞性睡眠呼吸暂停的患病率和负担。
Lancet Respir Med. 2019 Aug;7(8):687-698. doi: 10.1016/S2213-2600(19)30198-5. Epub 2019 Jul 9.
8
Symptom Subtypes of Obstructive Sleep Apnea Predict Incidence of Cardiovascular Outcomes.阻塞性睡眠呼吸暂停的症状亚型预测心血管结局的发生率。
Am J Respir Crit Care Med. 2019 Aug 15;200(4):493-506. doi: 10.1164/rccm.201808-1509OC.
9
Sex Differences in the Risk of Incident Hypertension With Sleep Apnea: Does Postmenopausal Status Matter?睡眠呼吸暂停患者发生高血压风险的性别差异：绝经后状态有影响吗？
Chest. 2017 Oct;152(4):695-697. doi: 10.1016/j.chest.2017.05.027.
10
CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea.持续气道正压通气治疗阻塞性睡眠呼吸暂停对心血管事件的预防作用。
N Engl J Med. 2016 Sep 8;375(10):919-31. doi: 10.1056/NEJMoa1606599. Epub 2016 Aug 28.
Zotero 插件